Abstract
Antimicrobial resistance (AMR) is a public health crisis that existed prior to the COVID-19 pandemic and will likely persist beyond it. While there were improvements in infection-related deaths during the twentieth century due to public health developments, vaccines, and antimicrobials, this progress is now at risk of being lost. The growth of AMR and recent emergence of novel infectious diseases have been exacerbated by antimicrobial overuse in humans, livestock, and agriculture. The possible overuse of antimicrobials due to the COVID-19 pandemic is also a cause for concern. Dermatologists, in particular, treat many skin conditions that warrant the utilization of antimicrobials. Consequently, dermatologists should be aware of local resistance development patterns and lower the risk of AMR by using directed therapy for the appropriate microbe, adjusting drug dosages to an effective level, prescribing antimicrobials judiciously, and providing education on AMR. It is imperative that dermatologists have an understanding of emerging infectious diseases and resistance development to effectively treat patients and combat AMR that has emerged in recent years.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AMR:
-
Antimicrobial resistance
- NSC:
-
National Security Council
- WHO:
-
World Health Organization
References
No Time to Wait: Securing the Future from Drug- Resistant Infections. United Nations Interagency Coordination Group on Antimicrobial Resistance 2019. https://www.who.int/antimicrobial-resistance/interagency-coordinationgroup/final-report/en.
Report to the President on Combating Antibiotic Resistance. President’s Council of Advisors on Science and Technology; 2014. https://obamawhitehouse.archives.gov/sites/default/files/microsites/ostp/PCAST/pcast_carb_report_sept2014.pdf.
Stern AM, Markel H. The history of vaccines and immunization: familiar patterns, new challenges. Health Aff (Millwood). 2005;24(3):611–21.
WHO: At least 80 million children under one at risk of diseases such as diphtheria, measles and polio as COVID-19 disrupts routine vaccination efforts, Warn Gavi, WHO and UNICEF. World Health Organization; 2020. https://www.who.int/news-room/detail/22-05-2020-at-least-80-million-children-under-one-at-risk-of-diseases-such-as-diphtheria-measles-and-polio-as-covid-19-disrupts-routine-vaccination-efforts-warn-gavi-who-and-unicef.
Kuehn BM. Alarming antimicrobial resistance trends emerge globally. JAMA. 2020;324(3):223.
Friedrich MJ. Venezuela’s infant death rate rises amid worsening humanitarian crisis. JAMA. 2019;321(11):1041.
McNeil D, Kaplan T. U.S. will revive global virus-hunting effort ended last year. The New York Times. 30 August 2020, p. A4.
Wilensky G. The importance of reestablishing a pandemic preparedness office at the White House. JAMA. 2020;324(9):830–1.
Shinkai K, Bruckner AL. Dermatology and COVID-19. JAMA. 2020;324(12):1133–4.
Centers for Disease Control and Prevention Outpatient antibiotic prescriptions: United States, 2018. https://www.cdc.gov/antibiotic-use/community/pdfs/Annual-Report-2018-H.pdf. Updated June 23, 2020.
Barbieri JS, Bhate K, Hartnett KP, Fleming- dutra KE, Margolis DJ. Trends in oral antibiotic prescription in dermatology, 2008 to 2016. JAMA Dermatol. 2019;155(3):290–7.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Khalfe, Y., Tyring, S.K. (2021). Summary: Overcoming Antimicrobial Resistance of the Skin. In: Tyring, S.K., Moore, S.A., Moore, A.Y., Lupi, O. (eds) Overcoming Antimicrobial Resistance of the Skin. Updates in Clinical Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-030-68321-4_16
Download citation
DOI: https://doi.org/10.1007/978-3-030-68321-4_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-68320-7
Online ISBN: 978-3-030-68321-4
eBook Packages: MedicineMedicine (R0)